Estimating population level disease prevalence using genetic risk scores
Benjamin D. EvansiD, Piotr SłowińskiiD, Andrew Tym HattersleyiD, Samuel E. JonesiD, Seth A. SharpiD, Robert A. KimmittiD, Michael N. WeedoniD, Richard A. OramiD, Krasimira T. Tsaneva-AtanasovaiD, Nicholas J. M. ThomasiD
Abstract
Clinical classification is essential for estimating disease prevalence but is difficult, often requiring complex investigations. The widespread availability of population level genetic data makes novel genetic stratification techniques a highly attractive alternative. We propose a generalizable mathematical framework for determining disease prevalence within a cohort using genetic risk scores. We compare and evaluate methods based on the means of genetic risk scores distributions; the Earth Movers Distance between distributions; a linear combination of kernel density estimates of distributions; and an Excess method. We demonstrate the performance of genetic stratification to produce robust prevalence estimates. Specifically, we show that robust estimates of prevalence are still possible even with rarer diseases, smaller cohort sizes and less discriminative genetic risk scores, highlighting the general utility of these approaches. Genetic stratification techniques offer exciting new research tools, enabling unbiased insights into disease prevalence and clinical characteristics unhampered by clinical classification criteria.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 14
- FWCI
- 1.27
- Field percentile
- top 21%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Power of Partnership: Democratizing Genetic Prevalence to Empower Patient Advocacy
Samantha M. Baxter, Moriel Singer‐Berk, … Anne O’Donnell‐Luria·medRxiv·Mar 31, 2026
- How genetic disease risks can be misestimated across global populations
Michelle S. Kim, Kane Patel, … Joseph Lachance·Genome biologyPeer-reviewed·Oct 26, 2018
- Benchmarking autosomal recessive disease prevalence estimation from allele frequencies against newborn screening data
Michael C. Sierant, Nicholas Knoblauch, … Arthur Wüster·medRxiv·Oct 11, 2025
- Performance of polygenic risk scores in screening, prediction, and risk stratification
Aroon Dinesh Hingorani, Jasmine Gratton, … NJ Wald·medRxiv·Feb 18, 2022
- Simulating genetic risk scores from summary statistics
Steven Squires, Michael N. Weedon, Richard A. Oram·medRxiv·May 17, 2024
- Liability-scale heritability estimation for biobank studies of low prevalence disease
Sven E. Ojavee, Zoltán Kutalik, Matthew R. Robinson·The American Journal of Human GeneticsPeer-reviewed·Oct 19, 2022